The constitutively activated BCR-ABL tyrosine kinase of chronic myeloid leukemia (CML) is localized exclusively to the cytoplasm despite the three nuclear localization signals (NLS) in the ABL portion of this fusion protein. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.